Activated nuclear factor kappa B and airway inflammation after smoke inhalation and burn injury in sheep

Journal of Burn Care and Research

Volumn 30, Issue 3, 2009, Pages 489-498

  Cox, Robert A ^a,d   Burke, Ann S ^b   Jacob, Sam ^a   Oliveras, Gloria ^b   Murakami, Kazunori ^c   Shimoda, Katsumi ^c   Enkhbaatar, Perenlei ^c   Traber, Lillian D ^c   Herndon, David N ^a   Traber, Daniel L ^c   Hawkins, Hal K ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b Shriners Burn Hospital for Children   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

^d SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOPEROXIDASE; SYNAPTOTAGMIN I; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS MUCOSA; CELL ACTIVATION; CELL MIGRATION; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; ENDOTHELIUM CELL; EPITHELIUM CELL; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; LUNG ALVEOLUS CELL TYPE 2; LUNG BURN; MACROPHAGE; MUCOSA CELL; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; SHEEP; TRANSCRIPTION INITIATION; ANIMAL; BURN; INFLAMMATION; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; BURNS; FEMALE; INFLAMMATION; NF-KAPPA B; PEROXIDASE; SHEEP, DOMESTIC; SMOKE INHALATION INJURY; SYNAPTOTAGMIN I;

EID: 67849128652     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e3181a28e13     Document Type: Article

References (38)

1. Shirani KZ, Moylan JA Jr, Pruitt BA Jr. The influence of inhalation injury and pneumonia on burn mortality. Ann Surg 1987;205:82-87.
2. Cox RA, Burke AS, Soejima K, et al. Airway obstruction in sheep with burn and smoke inhalation injuries. Am J Respir Cell Mol Biol 2003;29:295-302.
3. Cox RA, Mlcak RP, Chinkes DL, et al. Upper airway mucus deposition in lung tissue of burn trauma victims. Shock 2008; 29:356-361.
4. Cox RA, Burke AS, Oliveras G, et al. Acute bronchial obstruction in sheep: histopathology and gland cytokine expression. Exp Lung Res 2005;31:819-837.
5. Galindo M, Santiago B, Alcami J, Rivero M, Martín-Serrano J, Pablos JL. Hypoxia induces expression of the chemokines monocyte chemoattractant protein-1 (MCP-1) and IL-8 in human dermal fibroblasts. Clin Exp Immunol 2001;123: 36-41.
6. Karakurum M, Shreeniwas R, Chen J, et al. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J Clin Invest 1994;93:1564-1570.
7. Yamashita N, Koizumi H, Murata M, Mano K, Ohta K. Nuclear factor kappa B mediates interleukin-8 production in eosinophils. Int Arch Allergy Immunol 1999;120:230-236.
8. McCarron RM, Wang L, Stanimirovic DB, Spatz M. Endo-thelin induction of adhesion molecule expression on human brain microvascular endothelial cells. Neurosci Lett 1993; 156:31-34.
9. Matsui H, Ihara Y, Fujio Y, et al. Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-kappa B and NF-IL6 in cardiac myocytes. Cardiovasc Res 1999;42: 104-112.
10. Essani NA, Fisher MA, Jaeschke H. Inhibition of NF-kappa B activation by dimethyl sulfoxide correlates with suppression of TNF-alpha formation, reduced ICAM-1 gene transcription, and protection against endotoxin-induced liver injury. Shock 1997;7:90-96.
11. Christman JW, Sadikot RT, Blackwell TS. The role of nuclear factor-kappa B in pulmonary diseases. Chest 2000;117: 1482-1487.
12. Fan J, Ye RD, Malik AB. Transcriptional mechanisms of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2001;281: L1037-L1050.
13. Madjdpour L, Kneller S, Booy C, Pasch T, Schimmer RC, Beck-Schimmer B. Acid-induced lung injury: role of nuclear factor-kappaB. Anesthesiology 2003;99:1323-1332.
14. Quay JL, Reed W, Samet J, Devlin RB. Air pollution particles induce IL-6 gene expression in human airway epithelial cells via NF-kappaB activation. Am J Respir Cell Mol Biol 1998; 19:98-106.
15. Liden J, Ek A, Palmberg L, Okret S, Larsson K. Organic dust activates NF-kappaB in lung epithelial cells. Respir Med 2003;97:882-892.
16. Hargrave BY, Tiangco DA, Lattanzio FA, Beebe SJ. Cocaine, not morphine, causes the generation of reactive oxygen species and activation of NF-kappaB in transiently cotransfected heart cells. Cardiovasc Toxicol 2003;3:141-151.
17. Fan H, Sun B, Gu Q, Lafond-Walker A, Cao S, Becker LC. Oxygen radicals trigger activation of NF-kappaB and AP-1 and upregulation of ICAM-1 in reperfused canine heart. Am J Physiol Heart Circ Physiol 2002;282:H1778-H1786.
18. Ye RD. Regulation of nuclear factor kappaB activation by G-protein-coupled receptors. J Leukoc Biol 2001;70: 839-848.
19. Soejima K, McGuire R, Snyder N, et al. The effect of inducible nitric oxide synthase (iNOS) inhibition on smoke inhalation injury in sheep. Shock 2000;13:261-266.
20. Herndon DN, Traber DL, Niehaus GD, Linares HA, Traber LD. The pathophysiology of smoke inhalation injury in sheep model. J Trauma 1984;24:1044-1051.
21. Herndon DN, Traber LD, Linares H, et al. Etiology of the pulmonary pathophysiology associated with inhalation injury. Resuscitation 1986;14:43-59.
22. Baxter CR, Shires T. Physiological response to crystalloid resuscitation of severe burns. Ann N Y Acad Sci 1968;150: 874-894.
23. Sakano T, Okerberg CV, Shippee RL, Sanchez J, Mason AD Jr, Pruitt BA Jr. A rabbit model of inhalation injury. J Trauma 1993;34:411-416.
24. Enkhbaatar P, Murakami K, Shimoda K, et al. The inducible nitric oxide synthase inhibitor BBS-2 prevents acute lung injury in sheep after burn and smoke inhalation injury. Am J Respir Crit Care Med 2003;167:1021-1026. (Pubitemid 36408169)
25. Enkhbaatar P, Murakami K, Shimoda K, et al. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole attenuates acute lung injury in an ovine model. Am J Physiol Regul Integr Comp Physiol 2003;285:R366-R372.
26. Spitsin SV, Farber JL, Bertovich M, Moehren G, Koprowski H, Michaels FH. Human- and mouse-inducible nitric oxide synthase promoters require activation of phosphatidylcholine-specific phospholipase C and NF-kappa B. Mol Med 1997;3: 315-326.
27. Wu T, Chen Y, Chiang SK, Tso MO. NF-kappaB activation in light-induced retinal degeneration in a mouse model. Invest Ophthalmol Vis Sci 2002;43:2834-2840.
28. Wilson SJ, Leone BA, Anderson D, Manning A, Holgate ST. Immunohistochemical analysis of the activation of NF-kappaB and expression of associated cytokines and adhesion molecules in human models of allergic inflammation. J Pathol 1999;189:265-272.
29. Takeno S, Hirakawa K, Ueda T, Furukido K, Osada R, Yajin K. Nuclear factor-kappa B activation in the nasal polyp epithelium: relationship to local cytokine gene expression. Laryngoscope 2002;112:53-58.
30. Ellis RD, Goodlad JR, Limb GA, Powell JJ, Thompson RP, Punchard NA. Activation of nuclear factor kappa B in Crohn's disease. Inflamm Res 1998;47:440-445.
31. Kaltschmidt B, Deller T, Frotscher M, Kaltschmidt C. Ul-trastructural localization of activated NF-kappaB in granule cells of the rat fascia dentata. Neuroreport 2000;11: 839-844.
32. Wojcik C, DeMartino GN. Intracellular localization of pro-teasomes. Int J Biochem Cell Biol 2003;35:579-589.
33. Basbaum C, Lemjabbar H, Longphre M, Li D, Gensch E, McNamara N. Control of mucin transcription by diverse injury-induced signaling pathways. Am J Respir Crit Care Med 1999;160:S44- S48.
34. Barrow RE, Wang CZ, Yang SF, Zuo Q, Cox RA. Efficacy of cefazolin in promoting ovine tracheal epithelial repair. Respiration 1994;61:231-235.
35. Barrow RE, Wang CZ, Evans MJ, Herndon DN. Growth factors accelerate epithelial repair in sheep trachea. Lung 1993;171:335-344.
36. Brantley DM, Chen CL, Muraoka RS, et al. Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium. Mol Biol Cell 2001;12: 1445-1455.
37. Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996; 274:782-784.
38. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 1996;274:787-789.